FOLFIRI-BEVACIZUMAB

Leucovorin, 5-Fluorouracil, Irinotecan, Bevacizumab · Targeted Colorectal Regimen

Back to Cancer Drug Encyclopedia Find Recruiting Trials with this Drug →

Indications & Uses

First-line treatment of Metastatic Colorectal Cancer.

Contraindications

Gastrointestinal perforation, active serious hemorrhage, major surgery within 28 days.

Side Effects & Warnings

Hypertension, arterial thrombosis, proteinuria, hemorrhage, delayed wound healing, severe diarrhea.

Drug & Dietary Interactions

Extensive interactions; consult specific multi-agent administration and hydration protocols.

For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.

Patient & Caregiver Support

Ask About This Medication

Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.